10 April 2024 false No description of principal activity Taxfiler 2024.6 15631744business:PrivateLimitedCompanyLtd2024-04-102025-04-30 156317442024-04-09 156317442024-04-102025-04-30 15631744business:AuditExemptWithAccountantsReport2024-04-102025-04-30 15631744business:FilletedAccounts2024-04-102025-04-30 156317442025-04-30 15631744business:Director22024-04-102025-04-30 15631744business:Director32024-04-102025-04-30 15631744business:RegisteredOffice2024-04-102025-04-30 15631744core:WithinOneYear2025-04-30 15631744countries:EnglandWales2024-04-102025-04-30 15631744business:Micro-entities2024-04-102025-04-30 15631744business:Director12024-04-102025-04-30 iso4217:GBP xbrli:pure
Company Registration No. 15631744 (England and Wales)
Zato Pharma Limited Unaudited accounts for the period from 10 April 2024 to 30 April 2025
Zato Pharma Limited Annual report and unaudited accounts for the period from 10 April 2024 to 30 April 2025
CONTENTS
PAGE
Company information
3
Accountants' report
4
Statement of financial position
5
- 2 -
Zato Pharma Limited Company Information for the period from 10 April 2024 to 30 April 2025
Directors
ODUSHOLA, Kudrat Abeni Omotayo ODUSHOLA, Zainab Abimbola Titilope
Company Number
15631744 (England and Wales)
Registered Office
230 New Cross Road London London SE14 5PL England
Accountants
Crescent Heights 85 Great Portland Street LONDON W1W 7LT
- 3 -
Chartered Certified Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of Zato Pharma Limited for the period from 10 April 2024 to 30 April 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Zato Pharma Limited for the period from 10 April 2024 to 30 April 2025 as set out on pages 5 - 5 from the Company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/uk/en/about-us/regulation/rulebook.html
Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf.
Crescent Heights Chartered Certified Accountants 85 Great Portland Street LONDON W1W 7LT 19 August 2025
- 4 -
Zato Pharma Limited Statement of Financial Position as at 30 April 2025
2025 
£ 
Fixed assets
733 
Current assets
18,828 
Creditors: amounts falling due within one year
(19,440)
Net current liabilities
(612)
Total assets less current liabilities
121 
Net assets
121 
Capital and reserves
121 
NOTES TO THE ACCOUNTS
1 Statutory information
Zato Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15631744. The registered office is 230 New Cross Road, London, London, SE14 5PL, England.
2 Average number of employees
During the period the average number of employees was 2.
For the period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 19 August 2025
ODUSHOLA, Zainab Abimbola Titilope Director Company Registration No. 15631744
- 5 -